Passion, Persistence, and Patience with Dr. Robert Brodsky
Release Date: 11/15/2023
The Medicine Mentors Podcast
Lidia Schapira, MD, is a Professor of Medicine at Stanford Comprehensive Cancer Institute and Director of Stanford's Cancer Survivorship program. A nationally renowned expert in breast cancer, Dr. Schapira has pioneered workshops and helped develop innovative educational programs to improve the communication skills of cancer clinicians by building experienced and compassionate teams. She has been a champion of promoting patient activation and self-management at all phases of the cancer journey. She is the former Editor-in-Chief of cancer.net, and consultant editor for the Journal of...
info_outlineThe Medicine Mentors Podcast
Daniel Laheru , MD, is the Professor of Oncology and Co-Director of Skip Viragh Center for Pancreatic Cancer Research at the Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins Hospital. He holds the Ian MacMillian Professorship in Clinical Pancreatic Cancer Research. Dr. Laheru has developed a vaccine along with Dr. Elizabeth Jaffee, that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He is a Member of the Miller-Coulson Academy of Clinical Excellence, Member of...
info_outlineThe Medicine Mentors Podcast
Timothy Gilligan, MD, is the Vice-Chair for Education and Associate Professor of Medicine at the Cleveland Clinic Taussig Cancer Institute. He also serves as the Diversity, Equity and Inclusion Officer for Graduate Medical Education at Cleveland Clinic. He is a nationally recognized expert in Genitourinary Cancers and a thought leader in healthcare communication. He is President of the Academy of Communication in Healthcare and is the co-editor of the book Communication the Cleveland Clinic Way. “Find people who have a track record of mentorship. There are plenty of smart people who are...
info_outlineThe Medicine Mentors Podcast
Diane Reidy-Lagunes, MD, is the Vice Chair of Oncology Operations, Regional Cancer Network at Memorial Sloan Kettering Cancer Center. In the past, she has served as the President of Memorial Sloan Kettering Cancer Center Medical Staff. Dr. Reidy-Lagunes’ primary focus is treating gastrointestinal cancers and developing methods to integrate molecular-based therapies into the treatment of neuroendocrine tumors, as well as designing and conducting clinical trials to better treatment strategies for patients with this uncommon cancer type. At a national level, she is a member of the National...
info_outlineThe Medicine Mentors Podcast
Rachna Shroff, MD, is the Chief of the division of Hematology/Oncology and Associate Director for Clinical Research at the University of Arizona Cancer Center and the Associate Dean for Clinical and Translational Research at the University of Arizona College of Medicine. She is a clinical and translational investigator focused on developing novel targeted therapies and immunotherapies for pancreatic and hepatobiliary cancers and has led multiple clinical trials including the first randomized phase 3 trial in biliary cancers in the US. An internationally recognized expert, she is one of three...
info_outlineThe Medicine Mentors Podcast
Elizabeth Jaffee, MD, is an internationally recognized expert in cancer immunology and pancreatic cancer. She is the Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Co-director of the Skip Viragh Center for Pancreatic Cancer and Associate Director of the Bloomberg Kimmel Institute for Cancer Immunotherapy. Her research focuses on developing novel immunotherapies for the treatment and prevention of pancreatic cancer. Dr. Jaffee is a past president of AACR. She has served on a number of committees at the National Cancer Institute including the Co-chair of the...
info_outlineThe Medicine Mentors Podcast
Robert Mayer, MD, is the Faculty Vice President for Academic Affairs at Dana-Farber Cancer Institute and the Stephen B. Kay Professor of Medicine at Harvard Medical School, where he serves as the Faculty Associate Dean for Admissions. He directed the Dana Farber’s Medical Oncology Fellowship Program for over thirty years, overseeing the training of several hundred oncologists and established the Center for Gastrointestinal Oncology at Dana-Farber Cancer Institute. Dr. Mayer is a past president of American Society of Clinical Oncology and has been a recipient of numerous awards including...
info_outlineThe Medicine Mentors Podcast
Charles W. Sorenson, MD, is the President and CEO Emeritus of Intermountain Healthcare and the Founding Director of the Intermountain Healthcare Leadership Institute. Intermountain Healthcare is a not-for-profit system of 33 hospitals (including virtual hospitals), a Medical Group with more than 3,800 physicians and advanced practice clinicians at about 385 clinics. Prior to that, he served for eleven years as Intermountain’s Executive Vice President and Chief Operating Officer. Currently he serves as an Executive Coach at MEDI, the largest executive coaching firm in the nation dedicated...
info_outlineThe Medicine Mentors Podcast
Konstantinos Arnaoutakis, MD, is an Associate Professor of Medicine In the Division of Hematology and Oncology. He also serves as the Program Director of Hematology Oncology fellowship at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences. His primary research interests are lung cancer and novel therapies. He is the Coordinator of the Thoracic Malignancy disease-oriented committee (DOC). “They say it takes two to tango.” Recognizing the value of the mentoring relationship means understanding both sides have their own perspective. Join us in a...
info_outlineThe Medicine Mentors Podcast
Yelena Y. Janjigian, MD, is the Chief of the Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center. She is an internationally renowned medical oncologist who specializes in the treatment of malignancies of the gastrointestinal tract. Dr. Janjigian runs clinical and translational studies designed to develop better prevention, early diagnosis, staging and treatment strategies for patients with esophageal and stomach cancer. She is a recipient of numerous awards and was recently inducted as a member of American Society of Clinical Investigation. “Oftentimes, fellows will...
info_outlineRobert Brodsky, MD, is a world-renowned hematologist and the current Director of the Division of Hematology, as well as Professor of Medicine at Johns Hopkins University. He focuses on bone marrow failure states, specifically the use of bone marrow transplants in sickle cell disease and aplastic anemia. His lab studies complement mediated disorders and he has also developed the diagnostic assay that is used to diagnose PNH around the world. Dr. Brodsky is a recipient of numerous national awards and was recently elected as the President of the American Society of Hematology, the largest professional society of hematologists in the world.
“I remember driving down 83. I just couldn't wait to get into work…that excitement, that flutter in your heart, that's what defines success for me.” A sentiment passed down through now three generations of hematologists, Dr. Robert Brodsky, Director of the Division of Hematology at Johns Hopkins and President of the American Society of Hematology, joins us for a grounding conversation. Tune in as we dive into the leaders that showed him what it truly means to love your job, how asking the right research questions is the biggest predictor of success, and why it takes decades to build a career that’s worth having.
2. What is one of the biggest predictors of success? We connect it to the purpose behind the project: the Research Question. That's going to start the journey and create the flutter for us to come to work and pursue something that's actually going to have a meaningful change.
3. Life is likely to get more complicated as we move forward. The difficulty levels keep going up as we go to the next level, and therefore, if there's not a strong force driving us, we should not get to the next level just for the sake of getting there. It should be to reach an ultimate goal.